|
Re: One more Exempt Distribution - 2021-04-26
|
7
|
Resverlogix Corp.
|
Apr 28, 2021 10:55AM
|
|
Re: How many other "Alex Kopacz's" are out there...as we wait our turn on the tarmac?
|
2
|
Resverlogix Corp.
|
Apr 25, 2021 09:31PM
|
|
Re: Parallel Universe ?
|
5
|
Resverlogix Corp.
|
Apr 24, 2021 10:43AM
|
|
Re: Where is the trial?
|
2
|
Resverlogix Corp.
|
Apr 23, 2021 04:34PM
|
|
Re: Where is the trial?
|
4
|
Resverlogix Corp.
|
Apr 23, 2021 03:43PM
|
|
Re: Need help here, thanks
|
6
|
Resverlogix Corp.
|
Apr 22, 2021 10:10PM
|
|
Re: COVID 19 - Standard of Care
|
3
|
Resverlogix Corp.
|
Apr 22, 2021 04:33PM
|
|
Re: COVID 19 - Standard of Care
|
6
|
Resverlogix Corp.
|
Apr 22, 2021 03:18PM
|
|
Re: ZEN-3694 and Enzalutamide 2b Trial - Astella owns a piece of Xtandi (aka Enzalutamide)
|
5
|
Zenith Epigenetics
|
Apr 22, 2021 01:18PM
|
|
Re: Apabetalone’s Positive Impact on COVID-19 in Human Lung Cells Published in Biomedicines
|
5
|
Resverlogix Corp.
|
Apr 20, 2021 03:16PM
|
|
Re: Science and money
|
2
|
Resverlogix Corp.
|
Apr 20, 2021 10:41AM
|
|
Re: Still not finding on ClinicalTrials gov
|
2
|
Resverlogix Corp.
|
Apr 19, 2021 07:06PM
|
|
Re: Don's April 14th Interview on the Drive
|
8
|
Resverlogix Corp.
|
Apr 15, 2021 12:13PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
1
|
Resverlogix Corp.
|
Apr 14, 2021 11:55PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
8
|
Resverlogix Corp.
|
Apr 14, 2021 10:59PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 10:45PM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
6
|
Resverlogix Corp.
|
Apr 13, 2021 03:12PM
|
|
Give us just one or two NR’s - money, partners & timeframe
|
9
|
Resverlogix Corp.
|
Apr 13, 2021 01:50PM
|
|
Re: Volume
|
3
|
Zenith Epigenetics
|
Apr 13, 2021 01:37PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
5
|
Resverlogix Corp.
|
Apr 12, 2021 07:10PM
|
